glp 1 sglt2 Recent understandings about hypertension management in type 2 diabetes: What are the roles of inhibitor, GLP-1 receptor agonist, and finerenone? A step by step scheme

While youre here, take our regulatory intelligence chatbot for a spinfree: #Pharma #OTC #RegulatoryIntelligence #FreyrGRI #ComplianceSimplified To view or add a comment, sign in The FDA announces its upcoming research priorities for generic drugs in 2026

By the time your next injection is due, most people feel much better

This trial was important because a significant clinical benefit was seen in a lower-risk patient population irrespective of baseline cardiovascular risk

- Information regarding oral bioavailability comparison between orforglipron and semaglutide, as detailed in the cited study

Accessed March 25, 2026

Beneficial gut bacteria break down fibre in the intestine, encouraging the release of GLP-1 and improving fullness